RNU6-261P

Across TCGA pan-cancer cohorts, RNU6-261P RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated RNU6-261P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RNU6-261P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-261P expression acts as an unfavorable survival marker.

STAD, COAD, and THCA are the cancer types where RNU6-261P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	II,III,IV	0.161	0.542	<.001	78	view →
COAD	OS	Tertile	All	0.117	0.806	<.001	72	view →
THCA	DFS	Tertile	All	0.027	0.945	<.001	72	view →
BLCA	DFS	Tertile	All	0.196	0.627	.009	27	view →
SARC	DFS	Tertile	All	0.098	0.611	.006	18	view →
LGG	OS	Tertile	All	0.511	0.830	.042	9	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

RNU6-261P–STAD (DFS)

Open the STAD breakdown →